Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)-Reference-Cited by-同舟云学术

Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

Published:2019-05 Issue:5 Volume:51 Page:632-639
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Fiorino Gionata,Caprioli Flavio^ORCID,Daperno Marco,Mocciaro Filippo^ORCID,Principi Mariabeatrice,Viscido Angelo^ORCID,Fantini Massimo Claudio,Orlando Ambrogio,Papi Claudio^ORCID,Annese Vito,Danese Silvio,Vecchi Maurizio,Rizzello Fernando^ORCID,Armuzzi Alessandro,Leone Salvatore,Previtali Enrica,Aloi Marina,Alvisi Patrizia,Antonelli Elisabetta,Ardizzone Sandro,Astegiano Marco,Baldoni Monia,Beltrami Marina,Biancone Livia,Bodini Giorgia,Buda Andrea,Bossa Fabrizio,Bracci Fiammetta,Calabrese Emma,Cappello Maria,Castiglione Fabiana,Ciacci Carolina,Cicala Michele,Ciccocioppo Rachele,Comberlato Michele,Cortelezzi Claudio Camillo,Cosintino Rocco,Costa Francesco,Costantino Giuseppe,Cucchiara Salvatore,Cuomo Antonio,D’Incà Renata,Di Paolo Maria Carla,Di Sabatino Antonio,Di Sario Antonio,Frieri Giuseppe,Fries Walter,Gasbarrini Antonio,Geccherle Andrea,Gionchetti Paolo,Graziani Maria Giovanna,Grossi Laurino,Guidi Luisa,Imperiali Gianni,Latella Giovanni,Lionetti Paolo,Inserra Gaetano,Maconi Giovanni,Manguso Francesco,Marino Marco,Mastronardi Mauro,Mazzuoli Silvia,Meucci Gianmichele,Mendolaro Marco,Milla Monica,Mocci Giammarco,Monteleone Giovanni,Bortoluzzi Francesco Neri,Pagnini Cristiano,Pastorelli Luca,Pica Roberta,Piergallini Simona,Privitera Antonello,Renna Sara,Ribaldone Davide Giuseppe,Ricci Chiara,Rispo Antonio,Rocca Rodolfo,Romano Claudio,Romano Marco,Russo Giovanni,Sablich Renato,Saibeni Simone,Savarino Edoardo,Scribano Maria Lia,Spagnuolo Rocco,Stasi Elisa,Terpin Maria Maddalena,Testa Anna,Valpiani Daniela,Variola Angela,Vernia Piero,Vitale Giovanna,Zoli Giorgio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference60 articles.

1. Guidelines on evaluation of similar biotherapeutic products (SBPs) Expert Committee on Biological Standardization;World Health Organization,2009

2. Biosimilars in the EU: information guide for healthcare professionals;European Medicine Agency,2017

3. https://www.ema.europa.eu/medicines/human/EPAR/remicade.

4. https://www.ema.europa.eu/medicines/human/EPAR/humira.

5. https://www.ema.europa.eu/medicines/human/EPAR/inflectra.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Biological therapy for inflammatory bowel disease: cyclical rather than lifelong treatment?;BMJ Open Gastroenterology;2024-02

3. Initial prescriptions and medication switches of biological products: an analysis of prescription pathways and determinants in the Swiss healthcare setting;BMJ Open;2023-11

4. Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-10-29

5. Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason;Frontiers in Gastroenterology;2023-10-23